Efficacy and safety of anti-TNF agents in patients with enthesitis related arthritis

被引：0
|
作者：
P Tynjälä
V Honkanen
K Aalto
T Levälampi
机构：
[1] Hospital for Children and Adolsecents,
[2] Rheumatism Foundation Hospital,undefined
来源：
Pediatric Rheumatology | / 6卷 / Suppl 1期
关键词：
Public Health; Adverse Event; Arthritis; Male Patient; Infliximab;
D O I：
10.1186/1546-0096-6-S1-P37
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety
    Pires Lemos, Livia Lovato
    Costa, Juliana de Oliveira
    Almeida, Alessandra Maciel
    Oliveira Junior, Haliton
    Barbosa, Mariana Michel
    Kakehasi, Adriana Maria
    Acurcio, Francisco Assis
    [J]. RHEUMATOLOGY INTERNATIONAL, 2014, 34 (10) : 1345 - 1360
  • [22] Treatment of psoriatic arthritis with anti-TNF agents: a systematic review and meta-analysis of efficacy, effectiveness and safety
    Lívia Lovato Pires Lemos
    Juliana de Oliveira Costa
    Alessandra Maciel Almeida
    Haliton Oliveira Junior
    Mariana Michel Barbosa
    Adriana Maria Kakehasi
    Francisco Assis Acurcio
    [J]. Rheumatology International, 2014, 34 : 1345 - 1360
  • [23] Economic evaluation of anti-TNF agents for patients with rheumatoid arthritis in Greece
    Fragoulakis, Vasilis
    Vitsou, Elli
    Hernandez, Ana Cristina
    Maniadakis, Nikolaos
    [J]. CLINICOECONOMICS AND OUTCOMES RESEARCH, 2015, 7 : 85 - 93
  • [24] Maintenance of anti-TNF agents in rheumatoid arthritis patients in daily practice
    Schaeverbeke, T
    Dumoulin, C
    Richez, C
    Mehsen, N
    Bentaberry, F
    Monnier, A
    Dehais, J
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 301 - 301
  • [25] Anti-TNFα agents curb platelet activation in patients with rheumatoid arthritis
    Manfredi, Angelo A.
    Baldini, Mattia
    Camera, Marina
    Baldissera, Elena
    Brambilla, Marta
    Peretti, Giuseppe
    Maseri, Attilio
    Rovere-Querini, Patrizia
    Tremoli, Elena
    Sabbadini, Maria Grazia
    Maugeri, Norma
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (08) : 1511 - 1520
  • [26] Biologics beyond Anti-TNF Agents for Ulcerative Colitis - Efficacy, Safety, and Cost?
    Farrell, Richard J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (13): : 1279 - 1281
  • [27] SAFETY OF ANTI-TNF AGENTS IN PATIENTS WITH CIRRHOSIS: A CASE CONTROL STUDY
    Kapila, Nikhil
    Gonzalez, Adalberto
    Flocco, Gianina
    Salomon, Fayssa
    Hussain, Ishtiaq
    Melendez-Rosado, Jose
    Castro-Pavia, Fernando J.
    [J]. HEPATOLOGY, 2020, 72 : 726A - 727A
  • [28] Efficacy and safety of switching etanercept to an anti-TNF monoclonal antibody in patients with juvenile idiopathic arthritis.
    Russo, Ricardo A.
    Katsicas, Maria M.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S681 - S682
  • [29] EFFICACY AND SAFETY OF ANTI-TNFα THERAPIES IN RHEUMATOID ARTHRITIS PATIENTS IN CLINICAL PRACTICE: THREE YEARS EXPERIENCE
    Erra, A.
    Moreno, E.
    Tomas, C.
    Guahnon, L.
    Arnal, C.
    Alegre, C.
    Barcelo, P.
    Marsal, S.
    [J]. RHEUMATOLOGY, 2003, 42 : 89 - 89
  • [30] Efficacy and safety of anti-TNF therapies in rheumatoid arthritis patients in clinical practice: Three years experience
    Moreno, E
    Erra, A
    Guahnon, L
    Tomas, C
    Arnal, C
    Alegre, C
    Barcelo, P
    Marsal, S
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 166 - 166
12345